Diabetes Risk in Overweight, Obese Teens Varies Substantially by Baseline HbA1c

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, Jan. 30, 2024 -- Five-year diabetes risk among teens with overweight or obesity varies substantially by baseline HbA1c levels, according to a study published online Jan. 17 in JAMA Network Open.

Francis M. Hoe, M.D., from Kaiser Permanente Roseville Medical Center in California, and colleagues assessed the risk for future type 2 diabetes (T2D) among 74,552 adolescents (aged 10 to 17 years) with overweight and obesity.

The researchers found that the overall T2D incidence was 2.1 per 1,000 person-years, with a five-year cumulative incidence of 1.0 percent. A higher five-year cumulative T2D incidence was associated with higher baseline HbA1c (<5.5 percent to 5.5 to 5.6 percent: 0.3 to 0.5 percent; 5.7 to 5.8 percent: 1.1 percent; 5.9 to 6.0 percent: 3.8 percent; 6.1 to 6.2 percent: 11.0 percent; and 6.3 to 6.4 percent: 28.5 percent). Higher baseline HbA1c was associated with greater T2D risk compared with HbA1c <5.5 percent. Independent risk factors also included higher body mass index category, older age, female sex, and Asian or Pacific Islander race (hazard ratio, 1.7). Black race or Hispanic ethnicity were not risk factors compared with White race.

"These findings suggest that T2D surveillance in adolescents should be tailored based on HbA1c level, among other risk factors," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-31 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords